CEDIRANIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C25H27FN4O3
Molecular Weight	450.5053
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of CEDIRANIB

Structure Search

SMILES

COC1=C(OCCCN2CCCC2)C=C3N=CN=C(OC4=C(F)C5=C(NC(C)=C5)C=C4)C3=C1

InChI

InChIKey=XXJWYDDUDKYVKI-UHFFFAOYSA-N

InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C25H27FN4O3
Molecular Weight	450.5053
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:26:47 UTC 2023` Edited by `admin` on `Fri Dec 15 16:26:47 UTC 2023`
Record UNII	NQU9IPY4K9
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CEDIRANIB

Official Name

English

CEDIRANIB [USAN]

Common Name

English

AZD-2171

Code

English

cediranib [INN]

Common Name

English

Cediranib [WHO-DD]

Common Name

English

Quinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-

Systematic Name

English

4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-(3-PYRROLIDIN-1-YLPROPOXY)QUINAZOLINE

Systematic Name

English

CEDIRANIB [MART.]

Common Name

English

AZD2171

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C1967

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

NCI_THESAURUS

C1742

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

FDA ORPHAN DRUG

310510

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

WHO-ATC

L01XE32

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

EU-Orphan Drug

EU/3/14/1303

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

Code System Code Type Description

CAS

288383-20-0

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

INN

8764

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

USAN

TT-141

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

NCI_THESAURUS

C80867

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

EPA CompTox

DTXSID10183035

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

FDA UNII

NQU9IPY4K9

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

EVMPD

SUB26524

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

SMS_ID

100000090090

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

DRUG BANK

DB04849

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

ChEMBL

CHEMBL491473

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

WIKIPEDIA

CEDIRANIB

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

PUBCHEM

9933475

Created by admin on Fri Dec 15 16:26:48 UTC 2023 , Edited by admin on Fri Dec 15 16:26:48 UTC 2023

PRIMARY

Related Record Type Details


					9971WH3C6O

FETAL HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 3 (HUMAN)

METABOLIC ENZYME -> SUBSTRATE


					IHD25862WV

FETAL HEPATIC FLAVIN-CONTAINING MONOOXYGENASE 1 (HUMAN)

METABOLIC ENZYME -> SUBSTRATE


					6G09NND37S

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1

TARGET -> INHIBITOR


					OVI08ABI5H

MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT

TARGET -> INHIBITOR

Interaction Type:

INHIBITOR


					68AYS9A614

CEDIRANIB MALEATE

SALT/SOLVATE -> PARENT


					798536Z7S0

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2

TARGET -> INHIBITOR


					2Z7LDE78YX

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A4

METABOLIC ENZYME -> SUBSTRATE


					8FO9RM2OXK

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3

TARGET -> INHIBITOR

Related Record Type Details


					X2QY7DFS1F

QUINAZOLINE, 4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-(3-(1-OXIDO-1-PYRROLIDINYL)PROPOXY)-

METABOLITE -> PARENT

Comments:

IN VITRO

Interaction Type:

MINOR


					7SJ34L2BI5

1H-INDOLE-2-CARBOXYLIC ACID, 4-FLUORO-5-((6-METHOXY-7-(3-(1-PYRROLIDINYL)PROPOXY)-4-QUINAZOLINYL)OXY)-

METABOLITE -> PARENT

Comments:

IN VITRO

Interaction Type:

MINOR


					4270FV05PH

1-(3-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-QUINAZOLINYL)OXY)PROPYL)-1-.BETA.-D-GLUCOPYRANURONOSYLPYRROLIDINIUM

METABOLITE -> PARENT

Comments:

IN VITRO

Interaction Type:

MAJOR

Amount:

Related Record Type Details


					NQU9IPY4K9

CEDIRANIB

ACTIVE MOIETY